Back to search
🇺🇸

United States · US · US:0527-3290_47e50f93-a701-747e-e063-6294a90a5259

Levothyroxine Sodium

In shortageOrange BookUNIISPLATC H03AA01

Last synced from FDA National Drug Code directory (United States) on

Identification

ManufacturerLannett Company, Inc
CountryUS (United States)
ATC codeH03AA01
Dispensing
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026

Packs · 2

  • ndc11
    0527329043
    1000 TABLET in 1 BOTTLE (0527-3290-43)
  • ndc11
    0527329046
    90 TABLET in 1 BOTTLE (0527-3290-46)

Annotations

UNII (FDA Substance ID)
9J765S329G
LEVOTHYROXINE SODIUM
RxCUI 40144
Orange Book
N021342
AB1,AB2,AB3AB1,AB2,AB3AB1,AB2,AB3AB1,AB2,AB3AB1,AB2,AB3AB1,AB2,AB3AB1,AB2,AB3AB1,AB2,AB3
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Levothyroxine Sodium Tablet
Raw payload (JSON)
{
  "unii": {
    "unii": "9J765S329G",
    "rxcui": "40144",
    "inchikey": "JMHCCAYJTTWMCX-QWPJCUCISA-M",
    "display_name": "LEVOTHYROXINE SODIUM",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "spl_meta": {
    "5852d874-1ebc-49ff-b6c2-1dd513fca784": {
      "match": "brand_token",
      "title": "LEVOTHYROXINE SODIUM TABLET [BRYANT RANCH PREPACK]",
      "spl_version": "102",
      "published_date": "2026-05-28"
    }
  },
  "productid": "0527-3290_47e50f93-a701-747e-e063-6294a90a5259",
  "productndc": "0527-3290",
  "dosage_form": "TABLET",
  "orange_book": {
    "appl_no": "021342",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "001",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "002",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "003",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "004",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "005",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "006",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "007",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "008",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "009",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "010",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "011",
        "approval_date": "Mar 1, 2002"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB1,AB2,AB3",
        "strength": "0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
        "product_no": "012",
        "approval_date": "Dec 8, 2003"
      }
    ],
    "appl_type": "N"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "LEVOTHYROXINE SODIUM",
  "shortage_reason": "Levothyroxine Sodium Tablet",
  "shortage_status": "current",
  "proprietary_name": "Levothyroxine Sodium",
  "active_ingred_unit": "ug/1",
  "application_number": "NDA021342",
  "marketing_category": "NDA AUTHORIZED GENERIC",
  "nonproprietary_name": "Levothyroxine Sodium",
  "start_marketing_date": "20200803",
  "active_numerator_strength": "200"
}

Related drugs

Other records sharing ATC code H03AA01.

Access this data programmatically

Query Levothyroxine Sodium and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.